EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma

Hong Xiao, Hangyu Chen, Lei Zhang, Maimaitiyasen Duolikun, Baixin Zhen, Subinuer Kuerban, Xuehui Li, Yuxi Wang, Long Chen, Jian Lin

World Journal of Surgical Oncology · 2024

DOI: 10.1186/s12957-024-03417-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Surgical Oncology, 2024. Verfasst von Hong Xiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Hainan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Sorafenib, Liver Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although sorafenib has been consistently used as a first-line treatment for advanced hepatocellular carcinoma (HCC), most patients will develop resistance, and the mechanism of resistance to sorafenib needs further study.

Methods

Using KAS-seq technology, we obtained the ssDNA profiles within the whole genome range of SMMC-7721 cells treated with sorafenib for differential analysis. We then intersected the differential genes obtained from the analysis of hepatocellular carcinoma patients in GSE109211 who were ineffective and effective with sorafenib treatment, constructed a PPI network, and obtained hub genes. We then analyzed the relationship between the expression of these genes and the prognosis of hepatocellular carcinoma patients.

Results

In this study, we identified 7 hub ERGs (ACTB, CFL1, ACTG1, ACTN1, WDR1, TAGLN2, HSPA8) related to drug resistance, and these genes are associated with the cytoskeleton.

Conclusions

The cytoskeleton is associated with sorafenib resistance in hepatocellular carcinoma. Using KAS-seq to analyze the early changes in tumor cells treated with drugs is feasible for studying the drug resistance of tumors, which provides reference significance for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularSorafenibLiver NeoplasmsDrug Resistance, NeoplasmAntineoplastic AgentsHumansPrognosisGene Expression Regulation, NeoplasticCytoskeletonBiomarkers, TumorTumor Cells, CulturedCell Line, TumorCell ProliferationGene Expression Profiling

Stichwörter der Autor:innen

CytoskeletonDrug resistanceHepatocellular carcinomaKAS-seqSorafenib

Substanzen

SorafenibAntineoplastic AgentsBiomarkers, Tumor

Autor:innen und Institutionen

  • Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Hainan, China.
  • Department of Pharmacy, Peking University Third Hospital, 49 Huayuan North Rd, Haidian District, Beijing, 100191, China.
  • Department of Pharmacology, Xinjiang Medical University, Urumqi, China.
  • Department of Pharmacy, Peking University Third Hospital, 49 Huayuan North Rd, Haidian District, Beijing, 100191, China. lcchenlong@163.com.
  • Peking University, Third Hospital Cancer Center, 49 Huayuan North Rd, Haidian District, Beijing, 100191, China. lcchenlong@163.com.
  • Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Hainan, China. linjian@pku.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xiao, H., Chen, H., Zhang, L., Duolikun, M., Zhen, B., Kuerban, S., Li, X., Wang, Y., Chen, L., & Lin, J. (2024). Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma. World Journal of Surgical Oncology. https://doi.org/10.1186/s12957-024-03417-2

Vancouver

Xiao H, Chen H, Zhang L, Duolikun M, Zhen B, Kuerban S, et al. Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma. World Journal of Surgical Oncology. 2024. doi:10.1186/s12957-024-03417-2

BibTeX
@article{Xiao2024,
  author = {Xiao, Hong and Chen, Hangyu and Zhang, Lei and Duolikun, Maimaitiyasen and Zhen, Baixin and Kuerban, Subinuer and Li, Xuehui and Wang, Yuxi and Chen, Long and Lin, Jian},
  title = {Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma},
  journal = {World Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1186/s12957-024-03417-2}
}
Kostenlos starten →